GlycoMark Found to be Key Test for Managing Patients with Diabetes
GlycoMark Inc, New York, reports that results from the ongoing DURABLE clinical trial show the GlycoMark blood test is a better reflection of glucose, particularly after-meal glucose levels, than the gold standard hemoglobin A1C test in moderately controlled patients with diabetes.
Read More